All material subject to strictly enforced copyright laws. © 2021 Euromoney Institutional Investor PLC group
Asia EquityAsia IPOs

Jiangsu pharma firms eye first half for HK floats


Jiangsu Hansoh Pharmaceutical Co and Simcere Pharmaceutical Group are looking to raise a combined $2.5bn from Hong Kong IPOs that could launch in the first half of 2016.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree